Dakota Wealth Management Pfizer Inc Transaction History

Dakota Wealth Management

$4.35 Billion
Q3 2024

A detailed history of Dakota Wealth Management transactions in Pfizer Inc stock. As of the latest transaction made, Dakota Wealth Management holds 306,507 shares of PFE stock, worth $8.2 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

306,507

Previous 324,113 5.43%

Holding current value

$8.2 Million

Previous $9.07 Million 2.18%

% of portfolio

0.2%

Previous 0.22%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$27.7 - $31.39 $487,686 - $552,652	-17,606 Reduced 5.43%	306,507 $8.87 Million
Q2 2024 Jul 19, 2024	SELL	$25.26 - $29.6 $429,495 - $503,288	-17,003 Reduced 4.98%	324,113 $9.07 Million
Q1 2024 Apr 24, 2024	BUY	$25.89 - $29.73 $1.8 Million - $2.06 Million	69,378 Added 25.53%	341,116 $9.47 Million
Q4 2023 Jan 30, 2024	SELL	$26.13 - $33.94 $460,175 - $597,717	-17,611 Reduced 6.09%	271,738 $7.82 Million
Q3 2023 Oct 23, 2023	BUY	$32.09 - $37.51 $553,103 - $646,522	17,236 Added 6.33%	289,349 $9.6 Million
Q2 2023 Jul 31, 2023	BUY	$36.12 - $41.79 $2.58 Million - $2.99 Million	71,450 Added 35.61%	272,113 $9.98 Million
Q1 2023 Apr 14, 2023	SELL	$39.39 - $51.28 $281,756 - $366,805	-7,153 Reduced 3.44%	200,663 $8.19 Million
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $186,831 - $243,887	-4,475 Reduced 2.11%	207,816 $10.7 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $2.42 Million - $2.96 Million	-55,375 Reduced 20.69%	212,291 $9.29 Million
Q2 2022 Aug 05, 2022	BUY	$46.53 - $55.17 $2.79 Million - $3.31 Million	60,065 Added 28.93%	267,666 $14 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $8.51 Million - $10.6 Million	186,108 Added 865.9%	207,601 $10.7 Million
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $44,832 - $66,456	1,085 Added 5.32%	21,493 $1.27 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $19,507 - $25,058	497 Added 2.5%	20,408 $878,000
Q2 2021 Aug 02, 2021	BUY	$35.91 - $40.68 $51,351 - $58,172	1,430 Added 7.74%	19,911 $779,000
Q1 2021 May 10, 2021	SELL	$33.49 - $37.77 $1.66 Million - $1.88 Million	-49,651 Reduced 72.87%	18,481 $669,000
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $1.78 Million - $2.27 Million	-53,331 Reduced 43.91%	68,132 $2.51 Million
Q3 2020 Nov 04, 2020	BUY	$31.75 - $37.25 $2.54 Million - $2.98 Million	79,972 Added 192.75%	121,463 $4.46 Million
Q2 2020 Aug 07, 2020	SELL	$30.12 - $36.54 $50,029 - $60,692	-1,661 Reduced 3.85%	41,491 $1.36 Million
Q1 2020 Apr 29, 2020	BUY	$27.03 - $38.62 $438,399 - $626,377	16,219 Added 60.22%	43,152 $1.41 Million
Q4 2019 Feb 06, 2020	BUY	$32.92 - $37.36 $38,384 - $43,561	1,166 Added 4.53%	26,933 $1.06 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $787,720 - $1.02 Million	-24,245 Reduced 48.48%	25,767 $926,000
Q2 2019 Aug 07, 2019	SELL	$36.98 - $41.52 $706,502 - $793,239	-19,105 Reduced 27.64%	50,012 $2.17 Million
Q1 2019 Apr 18, 2019	SELL	$37.5 - $41.2 $470,625 - $517,060	-12,550 Reduced 15.37%	69,117 $534,000
Q4 2018 Jan 22, 2019	BUY	$38.47 - $43.86 $52,319 - $59,649	1,360 Added 1.69%	81,667 $3.59 Million
Q3 2018 Nov 07, 2018	BUY	$34.47 - $41.81 $1.28 Million - $1.55 Million	37,154 Added 86.1%	80,307 $3.54 Million
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $1.13 Million - $1.21 Million	34,386 Added 392.22%	43,153 $1.57 Million
Q1 2018 Apr 10, 2018	SELL	$31.91 - $37.02 $10,338 - $11,994	-324 Reduced 3.56%	8,767 $311,000
Q4 2017 Jan 16, 2018	BUY	$33.26 - $35.29 $72,673 - $77,108	2,185 Added 31.64%	9,091 $329,000
Q3 2017 Oct 16, 2017	BUY	$31.0 - $34.15 $214,086 - $235,839	6,906	6,906 $247,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dakota Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Dakota Wealth Management with notifications on news.

Account

Dakota Wealth Management Pfizer Inc Transaction History